Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From the prodromal stage of multiple sclerosis to disease prevention.
Marrie RA, Allegretta M, Barcellos LF, Bebo B, Calabresi PA, Correale J, Davis B, De Jager PL, Gasperi C, Greenbaum C, Helme A, Hemmer B, Kanellis P, Kostich W, Landsman D, Lebrun-Frenay C, Makhani N, Munger KL, Okuda DT, Ontaneda D, Postuma RB, Quandt JA, Roman S, Saidha S, Sormani MP, Strum J, Valentine P, Walton C, Zackowski KM, Zhao Y, Tremlett H. Marrie RA, et al. Among authors: helme a. Nat Rev Neurol. 2022 Sep;18(9):559-572. doi: 10.1038/s41582-022-00686-x. Epub 2022 Jul 15. Nat Rev Neurol. 2022. PMID: 35840705 Review.
Ethical use of off-label disease-modifying therapies for multiple sclerosis.
Laurson-Doube J, Rijke N, Helme A, Baneke P, Banwell B, Viswanathan S, Hemmer B, Yamout B. Laurson-Doube J, et al. Among authors: helme a. Mult Scler. 2021 Aug;27(9):1403-1410. doi: 10.1177/13524585211030207. Epub 2021 Jul 26. Mult Scler. 2021. PMID: 34304636 Free PMC article.
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.
Thompson AJ, Carroll W, Ciccarelli O, Comi G, Cross A, Donnelly A, Feinstein A, Fox RJ, Helme A, Hohlfeld R, Hyde R, Kanellis P, Landsman D, Lubetzki C, Marrie RA, Morahan J, Montalban X, Musch B, Rawlings S, Salvetti M, Sellebjerg F, Sincock C, Smith KE, Strum J, Zaratin P, Coetzee T. Thompson AJ, et al. Among authors: helme a. Mult Scler. 2022 Jan;28(1):16-28. doi: 10.1177/13524585211059766. Epub 2021 Dec 1. Mult Scler. 2022. PMID: 34850641 Free PMC article. Review.
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions.
Zaratin P, Vermersch P, Amato MP, Brichetto G, Coetzee T, Cutter G, Edan G, Giovannoni G, Gray E, Hartung HP, Hobart J, Helme A, Hyde R, Khan U, Leocani L, Mantovani LG, McBurney R, Montalban X, Penner IK, Uitdehaag BMJ, Valentine P, Weiland H, Bertorello D, Battaglia MA, Baneke P, Comi G; PROMS Initiative Working Groups. Zaratin P, et al. Among authors: helme a. Mult Scler Relat Disord. 2022 May;61:103757. doi: 10.1016/j.msard.2022.103757. Epub 2022 Mar 23. Mult Scler Relat Disord. 2022. PMID: 35367873 Free article.
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.
Simpson-Yap S, Pirmani A, De Brouwer E, Peeters LM, Geys L, Parciak T, Helme A, Hillert J, Moreau Y, Edan G, Spelman T, Sharmin S, McBurney R, Schmidt H, Bergmann A, Braune S, Stahmann A, Middleton R, Salter A, Bebo B, van der Walt A, Butzkueven H, Ozakbas S, Karabudak R, Boz C, Alroughani R, Rojas JI, van der Mei I, Sciascia do Olival G, Magyari M, Alonso R, Nicholas R, Chertcoff A, Zabalza A, Arrambide G, Nag N, Descamps A, Costers L, Dobson R, Miller A, Rodrigues P, Prčkovska V, Comi G, Kalincik T. Simpson-Yap S, et al. Among authors: helme a. Mult Scler Relat Disord. 2022 Oct;66:104072. doi: 10.1016/j.msard.2022.104072. Epub 2022 Jul 25. Mult Scler Relat Disord. 2022. PMID: 35917745 Free PMC article.
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.
Simpson-Yap S, Pirmani A, Kalincik T, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N, Hillert JA, Moreau Y, Edan G, Sharmin S, Spelman T, McBurney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton RM, Salter A, Bebo B, Van der Walt A, Butzkueven H, Ozakbas S, Boz C, Karabudak R, Alroughani R, Rojas JI, van der Mei IA, Sciascia do Olival G, Magyari M, Alonso RN, Nicholas RS, Chertcoff AS, de Torres AZ, Arrambide G, Nag N, Descamps A, Costers L, Dobson R, Miller A, Rodrigues P, Prčkovska V, Comi G, Peeters LM. Simpson-Yap S, et al. Among authors: helme a. Neurol Neuroimmunol Neuroinflamm. 2022 Aug 29;9(6):e200021. doi: 10.1212/NXI.0000000000200021. Print 2022 Nov. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36038263 Free PMC article.
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.
Solomon AJ, Marrie RA, Viswanathan S, Correale J, Magyari M, Robertson NP, Saylor DR, Kaye W, Rechtman L, Bae E, Shinohara R, King R, Laurson-Doube J, Helme A. Solomon AJ, et al. Among authors: helme a. Neurology. 2023 Aug 8;101(6):e624-e635. doi: 10.1212/WNL.0000000000207481. Epub 2023 Jun 15. Neurology. 2023. PMID: 37321866 Free PMC article.
WHO considers multiple sclerosis treatments essential.
Laurson-Doube J, Helme A, Nonino F, Piggott T, Rijke N, Saylor D. Laurson-Doube J, et al. Among authors: helme a. Lancet Neurol. 2024 Feb;23(2):140. doi: 10.1016/S1474-4422(23)00505-7. Lancet Neurol. 2024. PMID: 38267183 No abstract available.
World Brain Day 2021: a call to stop multiple sclerosis.
Wijeratne T, Grisold W, Baneke P, Helme A, King R, Carroll W. Wijeratne T, et al. Among authors: helme a. Lancet Neurol. 2021 Aug;20(8):597-598. doi: 10.1016/S1474-4422(21)00200-3. Epub 2021 Jun 21. Lancet Neurol. 2021. PMID: 34166643 No abstract available.
17 results